Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses

Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses

US Patent 8168589 · Granted May 1, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the treatment and/or prophylaxis of multiple sclerosis, and use of er2016
Use of EPO receptor activation or stimulation for the improvement of the EDSS sc2015
Use of erythropoietin and substances increasing and/or prolonging the activation2014
Method for the treatment of cerebral ischaemia and use of erythropoietin or eryt2009
Method of treating amytrophic lateral sclerosis using melatonin2008